Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Paratek Pharmaceuticals, Inc. - Common Stock
(NQ:
PRTK
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 20, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Paratek Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...
Via
Benzinga
Exposures
Product Safety
9 Health Care Stocks Showing Unusual Options Activity In Today's Session
May 03, 2021
Here's the list of some unusual options activity happening in today's session: Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 09, 2021
Gainers GT Biopharma (NASDAQ:GTBP) stock increased by 17.4% to $10.32 during Friday's regular session. Trading volume for this security as of 12:32 EST is 558.4K,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 23, 2021
April 23, 2021
Upgrades According to Northland Capital Markets, the prior rating for Clearfield Inc (NASDAQ:CLFD) was changed from Market Perform to Outperform. For the second quarter,...
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
April 09, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize...
Via
Benzinga
51 Biggest Movers From Friday
April 12, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.